MindWalk Holdings (HYFT) EBIT Margin (2020 - 2026)
MindWalk Holdings' (HYFT) quarterly EBIT Margin came in at 105.2% in Q2 2026, up 14635.0% year-over-year from N/an in Q2 2025, and down 19.06% quarter-over-quarter from 88.36% in Q1 2026.
Powered by 
Analysis
MindWalk Holdings (HYFT) EBIT Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has reported EBIT Margin for 7 consecutive years, with 105.2% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBIT Margin rose 14635.0% year-over-year to 105.2% in Q2 2026; TTM through Apr 2026 was 96.11%, a 10184.0% increase from a year earlier, with the FY2026 full-year figure at 96.01%, up 25133.0% from the prior year.
- EBIT Margin was 105.2% for Q2 2026 at MindWalk Holdings, down from 88.36% in the prior quarter.
- Over five years, EBIT Margin peaked at 287.01% in Q2 2024 and troughed at 120274.35% in Q3 2023.
- A 5-year average of 12028.44% and a median of 119.83% in 2023 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin sank 12006015 bps in 2023 and surged 12007726 bps in 2024, its largest moves.
- Over 5 years, EBIT Margin stood at 150.93% in 2022, then tumbled by 62086 bps to 93854.41% in 2023, then jumped by 100 bps to 151.33% in 2024, then surged by 56 bps to 67.29% in 2025, then tumbled by 56 bps to 105.2% in 2026.
- The last three EBIT Margin figures came in at 105.2% (Q2 2026), 88.36% (Q1 2026), and 67.29% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 20.76% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 6.68% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 11.94% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -218,381.69% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -105.20% |
| Jan 31, 2026 | -88.36% |
| Oct 31, 2025 | -67.29% |
| Jul 31, 2025 | -131.57% |
| Apr 30, 2025 | -251.55% |
| Jan 31, 2025 | -911.25% |
| Oct 31, 2024 | -151.33% |
| Jul 31, 2024 | -197.09% |
| Apr 30, 2024 | 287.01% |
| Jan 31, 2024 | -53.69% |
| Oct 31, 2023 | -93,854.41% |
| Jul 31, 2023 | -120,274.35% |
| Apr 30, 2023 | -108.09% |
| Jan 31, 2023 | -88.57% |
| Oct 31, 2022 | -150.93% |
| Jul 31, 2022 | -214.20% |
| Apr 30, 2022 | -81.83% |
| Jan 31, 2022 | -69.16% |
| Oct 31, 2021 | -94.09% |
| Jul 31, 2021 | -75.56% |